These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10895416)

  • 1. Modulating blood-brain barrier interactions of amino acid-based anticancer agents.
    Killian DM; Gharat L; Chikhale PJ
    Drug Deliv; 2000; 7(1):21-5. PubMed ID: 10895416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents.
    Killian DM; Chikhale PJ
    J Neurochem; 2001 Feb; 76(4):966-74. PubMed ID: 11181816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier.
    Chikhale EG; Chikhale PJ; Borchardt RT
    Biochem Pharmacol; 1995 Mar; 49(7):941-5. PubMed ID: 7741766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Abbott NJ; Begley DJ
    J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion technique.
    Mahar Doan KM; Lakhman SS; Boje KM
    Brain Res; 2000 Sep; 876(1-2):141-7. PubMed ID: 10973602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitated transport of the neurotoxin, beta-N-methylamino-L-alanine, across the blood-brain barrier.
    Smith QR; Nagura H; Takada Y; Duncan MW
    J Neurochem; 1992 Apr; 58(4):1330-7. PubMed ID: 1548467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
    Cornford EM; Young D; Paxton JW; Finlay GJ; Wilson WR; Pardridge WM
    Cancer Res; 1992 Jan; 52(1):138-43. PubMed ID: 1727374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature.
    Killian DM; Chikhale PJ
    Neurosci Lett; 2001 Jun; 306(1-2):1-4. PubMed ID: 11403943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.
    Takada Y; Greig NH; Vistica DT; Rapoport SI; Smith QR
    Cancer Chemother Pharmacol; 1991; 29(2):89-94. PubMed ID: 1760863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system.
    Greig NH; Momma S; Sweeney DJ; Smith QR; Rapoport SI
    Cancer Res; 1987 Mar; 47(6):1571-6. PubMed ID: 3815357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria.
    Zielke HR; Zielke CL; Baab PJ; Collins RM
    Neurochem Int; 2002 Apr; 40(4):347-54. PubMed ID: 11792465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
    Groothuis DR; Lippitz BE; Fekete I; Schlageter KE; Molnar P; Colvin OM; Roe CR; Bigner DD; Friedman HS
    Cancer Res; 1992 Oct; 52(20):5590-6. PubMed ID: 1394182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system.
    Killian DM; Hermeling S; Chikhale PJ
    Drug Deliv; 2007 Jan; 14(1):25-31. PubMed ID: 17107928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large neutral amino acids levels in primate cerebrospinal fluid do not confirm competitive transport under baseline conditions.
    Bongiovanni R; Mchaourab AS; McClellan F; Elsworth J; Double M; Jaskiw GE
    Brain Res; 2016 Oct; 1648(Pt A):372-379. PubMed ID: 27521685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical approach for assessing the transport of large neutral amino acids across the blood-brain barrier in man.
    Dahl RH; Berg RM
    Acta Neurobiol Exp (Wars); 2015; 75(4):446-56. PubMed ID: 26994422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier transport of L-tyrosine Conjugates: a model study for the brain targeting using large neutral amino acid transport system.
    Ohnishi T; Maruyama T; Higashi S; Awazu S
    J Drug Target; 2000; 8(6):395-401. PubMed ID: 11328665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutral amino acid transport across the human blood-brain barrier by phenylalanine.
    Shulkin BL; Betz AL; Koeppe RA; Agranoff BW
    J Neurochem; 1995 Mar; 64(3):1252-7. PubMed ID: 7861158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebrovascular transport of leucine as measured by the in situ brain perfusion technique.
    Smith QR; Takasato Y; Sweeney DJ; Rapoport SI
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):300-11. PubMed ID: 3988829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylalanine transport across the blood-brain barrier as studied with the in situ brain perfusion technique.
    Momma S; Aoyagi M; Rapoport SI; Smith QR
    J Neurochem; 1987 Apr; 48(4):1291-300. PubMed ID: 3819731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition for transport of amino acids into rat heart: effect of competitors on protein synthesis and degradation.
    Tovar AR; Tews JK; Torres N; Madsen DC; Harper AE
    Metabolism; 1992 Sep; 41(9):925-33. PubMed ID: 1518421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.